BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Li MR, Zhang SH, Chao K, Liao XH, Yao JY, Chen MH, Zhong BH. Apolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese population. World J Gastroenterol 2014; 20(38): 14010-14017 [PMID: 25320541 DOI: 10.3748/wjg.v20.i38.14010]
URL: https://www.wjgnet.com/1948-5182/full/v20/i38/14010.htm
Number Citing Articles
1
Yongjie Qi, Chen Chen, Xuejun Li, Yi Liu, Huiqin Qi, Yingchang Xue, Fengyong Yang. Silencing ApoC3 alleviates LPS-induced acute lung injury by inhibiting TLR signaling pathwayImmunologic Research 2023; 71(5): 687 doi: 10.1007/s12026-023-09379-z
2
Rui-Nan Zhang, Rui-Dan Zheng, Yu-Qiang Mi, Da Zhou, Feng Shen, Guang-Yu Chen, Chan-Yan Zhu, Qin Pan, Jian-Gao Fan. APOC3 rs2070666 Is Associated with the Hepatic Steatosis Independently of PNPLA3 rs738409 in Chinese Han Patients with Nonalcoholic Fatty Liver DiseasesDigestive Diseases and Sciences 2016; 61(8): 2284 doi: 10.1007/s10620-016-4120-7
3
Sara Saki, Nader Saki, Hossein Poustchi, Reza Malekzadeh. Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular EventsMiddle East Journal of Digestive Diseases 2020; 12(2): 65 doi: 10.34172/mejdd.2020.166
4
David Aguilar-Recarte, Xavier Palomer, Manuel Vázquez-Carrera. Uncovering the role of apolipoprotein C-III in insulin resistanceClínica e Investigación en Arteriosclerosis 2021; 33(2): 108 doi: 10.1016/j.arteri.2020.09.003
5
Yan Jiang, Junpeng Ma, Hao Li, Yi Liu, Chao You. Effect of apolipoprotein C3 genetic polymorphisms on serum lipid levels and the risk of intracerebral hemorrhageLipids in Health and Disease 2015; 14(1) doi: 10.1186/s12944-015-0047-9
6
Daniela Carmen Oniciu, Taishi Hashiguchi, Yuichiro Shibazaki, Charles L. Bisgaier, Pavel Strnad. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASHPLOS ONE 2018; 13(5): e0194568 doi: 10.1371/journal.pone.0194568
7
Wei-Kei Wong, Wah-Kheong Chan. Nonalcoholic Fatty Liver Disease: A Global PerspectiveClinical Therapeutics 2021; 43(3): 473 doi: 10.1016/j.clinthera.2021.01.007
8
Bing-Feng Chen, Yeuh Chien, Pin-Hsing Tsai, Pang-Chung Perng, Yi-Ping Yang, Kuan-Chun Hsueh, Chia-Hung Liu, Yuan-Hung Wang. A PRISMA-compliant meta-analysis of apolipoprotein C3 polymorphisms and nonalcoholic fatty liver diseaseJournal of the Chinese Medical Association 2021; 84(10): 923 doi: 10.1097/JCMA.0000000000000564
9
Eliza Christopoulou, Vasilios Tsimihodimos, Theodosios Filippatos, Moses Elisaf. Apolipoprotein CIII and diabetes. Is there a link?Diabetes/Metabolism Research and Reviews 2019; 35(3) doi: 10.1002/dmrr.3118
10
Fabio Salvatore Macaluso, Marcello Maida, Salvatore Petta. Genetic background in nonalcoholic fatty liver disease: A comprehensive reviewWorld Journal of Gastroenterology 2015; 21(39): 11088-11111 doi: 10.3748/wjg.v21.i39.11088
11
Soo Lim, Marja‐Riitta Taskinen, Jan Borén. Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndromeObesity Reviews 2019; 20(4): 599 doi: 10.1111/obr.12820
12
Karina Sato-Espinoza, Perapa Chotiprasidhi, Mariella R Huaman, Javier Díaz-Ferrer. Update in lean metabolic dysfunction-associated steatotic liver diseaseWorld Journal of Hepatology 2024; 16(3): 452-464 doi: 10.4254/wjh.v16.i3.452
13
Joost Willebrords, Isabel Veloso Alves Pereira, Michaël Maes, Sara Crespo Yanguas, Isabelle Colle, Bert Van Den Bossche, Tereza Cristina Da Silva, Cláudia Pinto Marques Souza de Oliveira, Wellington Andraus, Venâncio Avancini Alves, Bruno Cogliati, Mathieu Vinken. Strategies, models and biomarkers in experimental non-alcoholic fatty liver disease researchProgress in Lipid Research 2015; 59: 106 doi: 10.1016/j.plipres.2015.05.002
14
David Aguilar-Recarte, Xavier Palomer, Manuel Vázquez-Carrera. Uncovering the role of apolipoprotein C-III in insulin resistanceClínica e Investigación en Arteriosclerosis (English Edition) 2021; 33(2): 108 doi: 10.1016/j.artere.2021.04.002
15
Xiangyu Hu, Xiaoqin Jia, Cong Xu, Yingying Wei, Zhengbing Wang, George Liu, Qiang You, Guotao Lu, Weijuan Gong. Downregulation of NK cell activities in Apolipoprotein C-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cellsMetabolism 2021; 120: 154800 doi: 10.1016/j.metabol.2021.154800
16
Aalam Sohal, Hunza Chaudhry, Kris V. Kowdley. Genetic Markers Predisposing to Nonalcoholic SteatohepatitisClinics in Liver Disease 2023; 27(2): 333 doi: 10.1016/j.cld.2023.01.006
17
Giuseppina Umano, Mariangela Martino, Nicola Santoro. The Association between Pediatric NAFLD and Common Genetic VariantsChildren 2017; 4(6): 49 doi: 10.3390/children4060049
18
Xiao-Lin Li, Jian-Qing Sui, Lin-Lin Lu, Nan-Nan Zhang, Xin Xu, Quan-Yong Dong, Yong-Ning Xin, Shi-Ying Xuan. Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise reviewLipids in Health and Disease 2016; 15(1) doi: 10.1186/s12944-016-0221-8
19
Xiaoqing Huang, Wenfan Chen, Changsheng Yan, Renzhi Yang, Qiongyun Chen, Hongzhi Xu, Yuanpeng Huang. Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progressionBiomedicine & Pharmacotherapy 2019; 118: 109258 doi: 10.1016/j.biopha.2019.109258
20
Jing-Lu Jin, Yuan-Lin Guo, Jian-Jun Li. Apoprotein C-III: A review of its clinical implicationsClinica Chimica Acta 2016; 460: 50 doi: 10.1016/j.cca.2016.06.016
21
Kanuengnit Choochuay, Punna Kunhapan, Apichaya Puangpetch, Sissades Tongsima, Pornpen Srisawasdi, Abhasnee Sobhonslidsuk, Somnuek Sungkanuparph, Mohitosh Biswas, Chonlaphat Sukasem. Associations of <i>PNPLA3</i> and <i>LEP</i> genetic polymorphisms with metabolic-associated fatty liver disease in Thai people living with human immunodeficiency virusWorld Journal of Hepatology 2024; 16(3): 366-378 doi: 10.4254/wjh.v16.i3.366
22
Alexander J. Kovalic, Pratik Banerjee, Quynh T. Tran, Ashwani K. Singal, Sanjaya K. Satapathy. Genetic and Epigenetic Culprits in the Pathogenesis of Nonalcoholic Fatty Liver DiseaseJournal of Clinical and Experimental Hepatology 2018; 8(4): 390 doi: 10.1016/j.jceh.2018.04.001
23
Barbora Nováková, Radan Brůha. Serum markers in diagnostics of steatohepatitisVnitřní lékařství 2019; 65(9): 577 doi: 10.36290/vnl.2019.099
24
Fan Yuan, Zhan Gu, Yan Bi, Ruixue Yuan, Weibo Niu, Decheng Ren, Lei Zhang, Guang He, Bao-Cheng Liu. The association between rs1260326 with the risk of NAFLD and the mediation effect of triglyceride on NAFLD in the elderly Chinese Han populationAging 2022; 14(6): 2736 doi: 10.18632/aging.203970
25
Magdy M. Youssef, Amal Elshaer, Rizk Elbaz, Yehia A. Ellazek, Ahmad El-Waseef, Ahmad Settin. ApolipoproteinC3 Gene Variants in Nonalcoholic Fatty Liver Disease in EgyptAmerican Journal of Biochemistry and Molecular Biology 2017; 8(1): 16 doi: 10.3923/ajbmb.2018.16.22
26
Huanhuan Yang, Guochong Chen, Chunli Song, Deming Li, Qinghua Ma, Guangliang Chen, Xinli Li. A novel index including SNPs for the screening of nonalcoholic fatty liver disease among elder ChineseMedicine 2018; 97(13): e0272 doi: 10.1097/MD.0000000000010272
27
Qing-Yang Xu, Han Li, Hai-Xia Cao, Qin Pan, Jian-Gao Fan, Zhanjun Jia. APOC3 rs2070667 Associates with Serum Triglyceride Profile and Hepatic Inflammation in Nonalcoholic Fatty Liver DiseaseBioMed Research International 2020; 2020: 1 doi: 10.1155/2020/8869674
28
Ingrid Rivera‐Íñiguez, Karina González‐Becerra, Omar Ramos‐Lopez, Yolanda E. Peréz‐Beltrán, Marian S. Chagüén‐Hernández, Erika Martínez‐López, Edgar J. Mendivil. Lipid‐Related Genetic Variants for Personalized Dietary Interventions: A Systematic ReviewMolecular Nutrition & Food Research 2023; 67(14) doi: 10.1002/mnfr.202200675